Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Single-nephron proteomes connect morphology and function in proteinuric kidney disease.

Höhne M, Frese CK, Grahammer F, Dafinger C, Ciarimboli G, Butt L, Binz J, Hackl MJ, Rahmatollahi M, Kann M, Schneider S, Altintas MM, Schermer B, Reinheckel T, Göbel H, Reiser J, Huber TB, Kramann R, Seeger-Nukpezah T, Liebau MC, Beck BB, Benzing T, Beyer A, Rinschen MM.

Kidney Int. 2018 Jun;93(6):1308-1319. doi: 10.1016/j.kint.2017.12.012. Epub 2018 Mar 9.

PMID:
29530281
2.

N-Degradomic Analysis Reveals a Proteolytic Network Processing the Podocyte Cytoskeleton.

Rinschen MM, Hoppe AK, Grahammer F, Kann M, Völker LA, Schurek EM, Binz J, Höhne M, Demir F, Malisic M, Huber TB, Kurschat C, Kizhakkedathu JN, Schermer B, Huesgen PF, Benzing T.

J Am Soc Nephrol. 2017 Oct;28(10):2867-2878. doi: 10.1681/ASN.2016101119. Epub 2017 Jul 19.

3.

Single and Transient Ca2+ Peaks in Podocytes do not induce Changes in Glomerular Filtration and Perfusion.

Koehler S, Brähler S, Kuczkowski A, Binz J, Hackl MJ, Hagmann H, Höhne M, Vogt MC, Wunderlich CM, Wunderlich FT, Schweda F, Schermer B, Benzing T, Brinkkoetter PT.

Sci Rep. 2016 Oct 19;6:35400. doi: 10.1038/srep35400.

4.

The Risk of Musculoskeletal Adverse Events With Fluoroquinolones in Children: What Is the Verdict Now?

Binz J, Adler CK, So TY.

Clin Pediatr (Phila). 2016 Feb;55(2):107-10. doi: 10.1177/0009922815599959. Epub 2015 Aug 9. Review. No abstract available.

PMID:
26260402
5.

Synergistic Effects of a GPR119 Agonist with Metformin on Weight Loss in Diet-Induced Obese Mice.

Al-Barazanji K, McNulty J, Binz J, Generaux C, Benson W, Young A, Chen L.

J Pharmacol Exp Ther. 2015 Jun;353(3):496-504. doi: 10.1124/jpet.115.222828. Epub 2015 Mar 13.

PMID:
25770135
6.

Tuning the dielectric properties of metallic-nanoparticle/elastomer composites by strain.

Gaiser P, Binz J, Gompf B, Berrier A, Dressel M.

Nanoscale. 2015 Mar 14;7(10):4566-71. doi: 10.1039/c4nr06690a.

PMID:
25687891
7.

Interfacial bonding stabilizes rhodium and rhodium oxide nanoparticles on layered Nb oxide and Ta oxide supports.

Strayer ME, Binz JM, Tanase M, Shahri SM, Sharma R, Rioux RM, Mallouk TE.

J Am Chem Soc. 2014 Apr 16;136(15):5687-96. doi: 10.1021/ja412933k. Epub 2014 Apr 4.

PMID:
24654835
8.

Thermodynamic profiles at the solvated inorganic-organic interface: the case of gold-thiolate monolayers.

Ravi V, Binz JM, Rioux RM.

Nano Lett. 2013 Sep 11;13(9):4442-8. doi: 10.1021/nl402315z. Epub 2013 Aug 7.

PMID:
23924490
9.

Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats.

Conway JG, Pink H, Bergquist ML, Han B, Depee S, Tadepalli S, Lin P, Crumrine RC, Binz J, Clark RL, Selph JL, Stimpson SA, Hutchins JT, Chamberlain SD, Brodie TA.

J Pharmacol Exp Ther. 2008 Jul;326(1):41-50. doi: 10.1124/jpet.107.129429. Epub 2008 Apr 23.

PMID:
18434589
10.

GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats.

Chen L, Yang B, McNulty JA, Clifton LG, Binz JG, Grimes AM, Strum JC, Harrington WW, Chen Z, Balon TW, Stimpson SA, Brown KK.

J Pharmacol Exp Ther. 2005 Feb;312(2):718-25. Epub 2004 Oct 8.

PMID:
15475592
11.

Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.

Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, Desai B, MacKenzie KI, Mansfield TA, Kliewer SA, Goodwin B, Jones SA.

J Clin Invest. 2003 Dec;112(11):1678-87. Epub 2003 Nov 17.

12.

Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines.

Collins JL, Fivush AM, Watson MA, Galardi CM, Lewis MC, Moore LB, Parks DJ, Wilson JG, Tippin TK, Binz JG, Plunket KD, Morgan DG, Beaudet EJ, Whitney KD, Kliewer SA, Willson TM.

J Med Chem. 2002 May 9;45(10):1963-6.

PMID:
11985463
13.

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.

Brown KK, Henke BR, Blanchard SG, Cobb JE, Mook R, Kaldor I, Kliewer SA, Lehmann JM, Lenhard JM, Harrington WW, Novak PJ, Faison W, Binz JG, Hashim MA, Oliver WO, Brown HR, Parks DJ, Plunket KD, Tong WQ, Menius JA, Adkison K, Noble SA, Willson TM.

Diabetes. 1999 Jul;48(7):1415-24.

PMID:
10389847
14.

The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction.

Lenhard JM, Lancaster ME, Paulik MA, Weiel JE, Binz JG, Sundseth SS, Gaskill BA, Lightfoot RM, Brown HR.

Diabetologia. 1999 May;42(5):545-54.

PMID:
10333046

Supplemental Content

Support Center